FNY Investment Advisers’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-2,081
Closed -$140K 1061
2025
Q3
$140K Buy
+2,081
New +$165K 0.05% 325
2019
Q2
Sell
-200
Closed -$5K 1010
2019
Q1
$5K Sell
200
-156
-44% -$5.48K ﹤0.01% 504
2018
Q4
$10K Buy
+356
New +$11.3K ﹤0.01% 415

Other funds holding DXCM

FNY Investment Advisers's DXCM Position: Q4 2025 in Review

FNY Investment Advisers sold out of DexCom (DXCM) in Q4 2025, closing a stake of 2,081 shares — an estimated $140K sold.

FNY Investment Advisers first reported a position in DXCM in Q4 2018 and held it in 3 quarters. The position peaked at $140K in Q3 2025. 921 funds tracked by Wall St. Rank hold DXCM as of Q4 2025.

  • FNY Investment Advisers reported no remaining DexCom position as of Q4 2025 after selling out during the quarter.
  • FNY Investment Advisers sold 2,081 DexCom shares in Q4 2025, an estimated $140K.
  • FNY Investment Advisers first reported a position in DexCom in Q4 2018 and held it in 3 quarters.
  • FNY Investment Advisers's DexCom position peaked at $140K in Q3 2025.
  • 921 funds tracked by Wall St. Rank held DexCom as of Q4 2025.

Based on FNY Investment Advisers's 13F filing for Q4 2025, filed 16 Jan 2026.